Members

Our focus Cortalix operates through three main pillars: Internal Programs : We are advancing clinical candidates targeting PDGFRA, PDGFRB, FAP, IGF2R, and EGFR for applications in ImmunoPET imaging, targeted ImmunoRT, and immunotherapy, particularly in fibrosis and fibrotic cancers. These programs are available for licensing. Partner Programs : We collaborate with companies and academic research groups to screen and select suitable sdAb candidates for novel targets using our synthetic sdAb discovery platform. We assist in developing these sdAbs into fully-fledged applications and facilitate connections with downstream partners for production. Services : We offer stand-alone sdAb selection and development projects on a fee-for-service basis for CROs, biotech and pharma companies, and research groups. Applications include targeted therapy, immunotherapy, research tools, and bioanalytical applications such as immunohistochemistry, fluorescence imaging, tailored affinity columns, and ELISA development and validation. Our mission At Cortalix, our mission is to leverage modern, affordable, and animal-free nanobody library technology to develop next-generation diagnostics, therapeutics, and bio-analytical tools. Headquartered in Groningen, Netherlands, we are committed to supporting scientific innovation through our expertise in single-domain antibodies. Website: www.cortalix.com

The combination of a small dedicated team of experts, an innovative environment and state-of-the-art facilities enables CTC Netherlands to effectively address the specific needs of early phase patient studies, offering comprehensive support for our clients. CTC Netherlands is part of the “Center for Translational Research” , a group of complementary life science service companies, including “CTC Clinical Trials Consultants AB” , headquartered in Uppsala, Sweden. Website: https://ctc-netherlands.com/

DEMCON is a fast-growing business that supports clients with a wide range of competencies. As a system supplier, DEMCON can meet the entire needs of its clients, from proof of principle, prototype and pre-production to serial production. In 25 years, the business has grown to become the DEMCON Group (with more than 440 employees in 2018). The head office is situated in Enschede, with subsidiary locations in Son, Oldenzaal, Groningen, Delft and Münster (Germany). DEMCON has clients worldwide, from the Netherlands and Germany to Asia and the US. Zernike Campus DEMCON has chosen to establish itself on the Zernike Campus, the hub for science and engineering in the northern part of the city of Groningen. Schipper explains: “Edward van der Meer, director of the campus, helped us with our introduction to Groningen and finding suitable housing. We are moving into a multi-tenant business building, where we will also bring together our activities from Roden.” In Roden, DEMCON has worked in recent years on applications for measuring muscle tension in respiratory muscles, for example, in prematurely born children. This expertise is particularly relevant for DEMCON’s subsidiary, DEMCON macawi respiratory systems , which develops and produces ventilators for patients of all ages. Website: https://www.demcon.nl/